Piperacillin concentration in relation to therapeutic range in critically ill patients–a prospective observational study

J Zander, G Döbbeler, D Nagel, B Maier, C Scharf… - Critical Care, 2016 - Springer
Background Piperacillin levels after standard dosing have been shown frequently to be
subtherapeutic, especially when renal clearance was augmented. Here, we aimed to …

Pharmacokinetics and pharmacodynamics of piperacillin/tazobactam when administered by continuous infusion and intermittent dosing

DS Burgess, T Waldrep - Clinical therapeutics, 2002 - Elsevier
Background: Although intermittent bolus dosing is currently the standard of practice for many
antimicrobial agents, beta-lactams exhibit time-dependent bacterial killing. Maximizing the …

Population pharmacokinetics of piperacillin in nonobese, obese, and morbidly obese critically ill patients

AS Alobaid, SC Wallis, P Jarrett, T Starr… - Antimicrobial agents …, 2017 - Am Soc Microbiol
The treatment of infections in critically ill obese and morbidly obese patients is challenging
because of the combined physiological changes that result from obesity and critical illness …

Evaluating outcomes associated with alternative dosing strategies for piperacillin/tazobactam: a qualitative systematic review

GT Mah, VH Mabasa, I Chow… - Annals of …, 2012 - journals.sagepub.com
Objective: To perform a qualitative systematic review of the evidence comparing traditional
strategies against prolonged intermittent or continuous infusion strategies for piperacillin …

Identification of optimal renal dosage adjustments for traditional and extended-infusion piperacillin-tazobactam dosing regimens in hospitalized patients

N Patel, MH Scheetz, GL Drusano… - Antimicrobial agents and …, 2010 - Am Soc Microbiol
This study examined the effect of various levels of renal impairment on the probability of
achieving free drug concentrations that exceed the MIC for 50% of the dosing interval (50% f …

Pharmacokinetic evaluation of piperacillin-tazobactam

Y Hayashi, JA Roberts, DL Paterson… - Expert opinion on drug …, 2010 - Taylor & Francis
Importance of the field: Piperacillin-tazobactam is a frequently prescribed intravenous
antibiotic for moderate to severe infections used in hospital settings because of its broad …

Population pharmacokinetics and pharmacodynamics of continuous versus short-term infusion of imipenem-cilastatin in critically ill patients in a randomized …

SG Sakka, AK Glauner, JB Bulitta… - Antimicrobial agents …, 2007 - Am Soc Microbiol
Beta-lactams are regularly administered in intermittent short-term infusions. The percentage
of the dosing interval during which free drug concentrations exceed the MIC (fT> MIC) is the …

Pharmacodynamics of piperacillin alone and in combination with tazobactam against piperacillin-resistant and-susceptible organisms in an in vitro model of infection

AH Strayer, DH Gilbert, P Pivarnik… - Antimicrobial agents …, 1994 - Am Soc Microbiol
The pharmacodynamics of dosage regimens of piperacillin alone or in combination with
tazobactam against piperacillin-resistant or-susceptible bacteria were studied in an in vitro …

Pharmacokinetic-pharmacodynamic modelling of the in vitro antiinfective effect of piperacillin-tazobactam combinations.

T Dalla Costa, A Nolting, K Rand… - International journal of …, 1997 - europepmc.org
Purpose The aim of the study was to investigate the in vitro antiinfective effect of piperacillin-
tazobactam (PIP-TZB) combinations on Escherichia coli in simulations of free concentration …

Pharmacokinetic analysis of piperacillin administered with tazobactam in critically ill, morbidly obese surgical patients

AW Sturm, N Allen, KD Rafferty, DN Fish… - … : The Journal of …, 2014 - Wiley Online Library
Study Objective To evaluate the steady‐state pharmacokinetic and pharmacodynamic
parameters of piperacillin in morbidly obese, surgical intensive care patients. Design Open …